Chuck Donnelly and Julie Morrison - SaaS for Pre-Clinical Trials

<p><span style="color: #d35400;"><strong>Join Sal Daher's Investment Syndicate List:</strong></span> <strong><a href= "https://www.angelinvestboston.com/our-syndicates">Click to Join</a></strong></p> <p>RockStep Solutions improves efficiency by 70% according to one client. This is why the startup is getting word of mouth traffic from clients running in vivo drug trials. Founders Chuck Donnelly and Julie Morrison tell their story and share valuable wisdom about this intersection of software and bio.</p> <p>Highlights include:</p> <ul> <li>Sal Daher Introduces Chuck Donnelly and Julie Morrison, the Founders of RockStep Solutions</li> <li>RockStep Provides a SaaS Solution for a Sector of the Drug Discovery Space That Is Poorly Served by Existing Vendors</li> <li>“The problem that we're solving is data chaos in drug discovery.”</li> <li>“…we have one of our customers that's projecting a 70% efficiency gain.”</li> <li>“We bring value to the pharmaceutical companies by speeding up that pipeline, reducing the number of errors that happen.”</li> <li>“While I was at Jackson Lab… We recognized that there was this gap, if you will, that we just talked about. The NIH actually funded us.”</li> <li>“One full day of my work week was designed to take all my data out of paper and put it into Excel even.”</li> <li>"But they don't actually have any money." I said, "I'm not sure it matters at this point because I'm so passionate about the problem they're solving."</li> <li>“I can tell you that these equity-only deals work very rarely…”</li> <li>On co-founders: “You have to be aligned on your personal values because this is a marriage. In very many ways it's similar.”</li> <li>“There's no question, your family is part of this company. You will not have a work-life balance.”</li> <li>“Ultimately, if we don't get the pricing right, we're not going to succeed. You have to get your pricing right.”</li> <li>“…they're just academic customers paying, I think our cheapest is $50 a user. Right now, in industry we're getting $1,800 per user. T